Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patients.

Psychopharmacology - 1 Apr 2012

Greenbaum Lior, Smith Robert C, Lorberboym Mordechai, Alkelai Anna, Zozulinsky Polina, Lifschytz Tzuri, Lifshytz Tzuri, Kohn Yoav, Djaldetti Ruth, Lerer Bernard

Abstract excerpt

RATIONALE: Antipsychotic-induced parkinsonism (AIP) is a severe adverse affect of antipsychotic drug treatment. Recently, our group performed a genome-wide association study (GWAS) for AIP severity, and identified several potential AIP risk variants. OBJECTIVES: The aim of this study was to validate our original AIP-GWAS susceptibility variants and to understand their possible function. METHODS: We conducted a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Corpus Striatum

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Israel

Share to Parkinson Disease

Share to Parkinson Disease, Secondary

Share to Substantia Nigra

Share to Tomography, Emission-Computed, Single-Photon

Source

Identifiers

PMID: 21947317
DOI: 10.1007/s00213-011-2499-6

Genes

AIP
ZFPM2
CIT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patients.PMID 21947317Read ↗

Genome-wide association study of antipsychotic-induced parkinsonism severity among schizophrenia patients.Semantic proximity Read ↗

Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia.Semantic proximity Read ↗

Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic PatientsSemantic proximity Read ↗

Integrating Genome-wide and Epigenome-wide Associations for Antipsychotic Induced Extrapyramidal Side EffectsSemantic proximity Read ↗

Integrating genome-wide and epigenome-wide associations for antipsychotic induced extrapyramidal side effects.Semantic proximity Read ↗

Pharmacogenetics of tardive dyskinesia: an updated review of the literature.Semantic proximity Read ↗

Genomewide association study of movement-related adverse antipsychotic effects.Semantic proximity Read ↗

Genome-Wide Association Study Suggested the PTPRD Polymorphisms Were Associated With Weight Gain Effects of Atypical Antipsychotic Medications.Semantic proximity Read ↗

Support for association of HSPG2 with tardive dyskinesia in Caucasian populations.Semantic proximity Read ↗

Identifying key transcription factors for pharmacogenetic studies of antipsychotics induced extrapyramidal symptoms.Semantic proximity Read ↗

Genome-wide association mapping of loci for antipsychotic-induced extrapyramidal symptoms in mice.Semantic proximity Read ↗

Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychoticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.